GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Formycon AG (XTER:FYB) » Definitions » Forward Dividend Yield %

Formycon AG (XTER:FYB) Forward Dividend Yield % : 0.00% (As of Jun. 11, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Formycon AG Forward Dividend Yield %?

As of today (2024-06-11), the Forward Annual Dividend Yield of Formycon AG is 0.00%.

As of today (2024-06-11), the Trailing Annual Dividend Yield of Formycon AG is 0.00%.

XTER:FYB's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.66
* Ranked among companies with meaningful Forward Dividend Yield % only.

Formycon AG's Dividends per Share for the six months ended in Dec. 2023 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Formycon AG's Forward Dividend Yield %

For the Biotechnology subindustry, Formycon AG's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Formycon AG's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Formycon AG's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Formycon AG's Forward Dividend Yield % falls into.



Formycon AG Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Formycon AG  (XTER:FYB) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Formycon AG Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Formycon AG's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Formycon AG (XTER:FYB) Business Description

Traded in Other Exchanges
Address
Fraunhoferstrasse 15, Martinsried, Planegg, BY, DEU, 82152
Formycon AG is a pharmaceutical company. It is engaged in the development of pharmaceutical and biopharmaceutical products and the development of drug delivery systems. Its focus is on treatments in ophthalmology and immunology as well as other chronic diseases. The company's pipeline in the biosimilar drugs category includes FYB201, FYB202, FYB203, and FYB207 for the treatment of COVID 19. It is also engaged in the provision of diagnostic laboratory services and works for third parties and the carrying out of diagnostic laboratory services.
Executives
Dr. Stefan Glombitza Board of Directors
Dr. Carsten Brockmeyer Board of Directors
Dr. Nicolas Combé Board of Directors

Formycon AG (XTER:FYB) Headlines

No Headlines